Strategic partnerships Leverage Clear Guide Medical’s Johns Hopkins origin and ongoing collaboration with Hopkins researchers to position joint academic-industry pilot programs that validate imaging fusion in real-world clinical workflows, creating credibility for hospitals and imaging centers.

Clinical expansion Target minimally invasive interventional procedures such as biopsies, ablations, nerve blocks, and lumbar punctures where real-time navigation and image fusion can improve first-pass success, patient safety, and throughput.

Tech-enabled ROI Highlight the cost-efficiency and workflow improvements of the CLEAR GUIDE SCENERGY family to attract procurement teams seeking value-based imaging guidance solutions that reduce procedure time and need for repeat attempts.

Early-stage traction Capitalize on NIH funding and recent university partnerships to engage research-hospital sites for early adoption studies, offering co-development and data-sharing opportunities that can de-risk procurement for larger health systems.

Growth-ready fit Position as a scalable, private-label or integration-ready platform for mid-market and larger imaging groups, underscored by a lean team and proven clinical use cases to compete with larger vendors in the ultrasound-CT/MRI fusion space.